3 Reasons OCUL is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
Is It Too Late To Consider Ocular Therapeutix (OCUL) After Recent Share Price Volatility? [Yahoo! Finance]
Ocular Therapeutix (NASDAQ:OCUL) Surprises With Q3 CY2025 Sales [Yahoo! Finance]
BofA Bullish on Ocular Therapeutix (OCUL) as AXPAXLI Targets Superiority Label and Faster Regulatory Path in Wet AMD [Yahoo! Finance]
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.